These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11266748)

  • 41. Combined use of rapamycin and leflunomide in prevention of acute cardiac allografts rejection in rats.
    Sun Y; Chen X; Zhao J; Zou X; Li G; Li X; Shen B; Sun S
    Transpl Immunol; 2012 Aug; 27(1):19-24. PubMed ID: 22538197
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The use of CD4 and CD8 knockout mice to study the role of T-cell subsets in allotransplant rejection.
    Krieger NR; Fathman CG
    J Heart Lung Transplant; 1997 Mar; 16(3):263-7. PubMed ID: 9087868
    [No Abstract]   [Full Text] [Related]  

  • 43. Anti-CD44 monoclonal antibody inhibits heart transplant rejection mediated by alloantigen-primed CD4(+) memory T cells in nude mice.
    Wang F; Chen J; Shao W; Xie B; Wang Y; Lan T; Thorlacius H; Qi Z
    Immunol Invest; 2010; 39(8):807-19. PubMed ID: 20718664
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intensity of transplant chronic rejection correlates with level of graft-infiltrating regulatory cells.
    Semiletova NV; Shen XD; Baibakov B; Andakyan A
    J Heart Lung Transplant; 2010 Mar; 29(3):335-41. PubMed ID: 20080050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. As originally published in 1994: Development of tolerance to experimental cardiac allograft in utero. Updated in 2001.
    DiSesa VJ; Mohiuddin MM
    Ann Thorac Surg; 2001 Feb; 71(2):755-6. PubMed ID: 11235756
    [No Abstract]   [Full Text] [Related]  

  • 46. Blockade of the CD40 pathway fails to prevent CD8 T cell-mediated intestinal allograft rejection.
    Meng L; Guo Z; Kim O; He G; Hart J; Szot GL; Wang J; Pearson TC; Larsen CP; Newell KA
    Transplant Proc; 2001; 33(1-2):418-20. PubMed ID: 11266891
    [No Abstract]   [Full Text] [Related]  

  • 47. Mechanisms of targeting CD28 by a signaling monoclonal antibody in acute and chronic allograft rejection.
    Dong VM; Yuan X; Coito AJ; Waaga AM; Sayegh MH; Chandraker A
    Transplantation; 2002 Apr; 73(8):1310-7. PubMed ID: 11981427
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of ICAM-1 in chronic rejection in the rat heart transplantation model.
    Hamano K; Ito H; Suzuki K; Shirasawa B; Gohra H; Katoh T; Fujimura Y; Tsuboi H; Esato K
    Transplant Proc; 1996 Jun; 28(3):1822. PubMed ID: 8658899
    [No Abstract]   [Full Text] [Related]  

  • 49. CD40-CD40 ligand-independent activation of CD8+ T cells can trigger allograft rejection.
    Jones ND; Van Maurik A; Hara M; Spriewald BM; Witzke O; Morris PJ; Wood KJ
    J Immunol; 2000 Jul; 165(2):1111-8. PubMed ID: 10878390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
    Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A
    Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts.
    Jones TR; Ha J; Williams MA; Adams AB; Durham MM; Rees PA; Cowan SR; Pearson TC; Larsen CP
    J Immunol; 2002 Feb; 168(3):1123-30. PubMed ID: 11801646
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The cellular basis of cardiac allograft rejection. IX. Ratio of naïve CD4+CD25+ T cells/CD4+CD25- T cells determines rejection or tolerance.
    Nomura M; Plain KM; Verma N; Robinson C; Boyd R; Hodgkinson SJ; Hall BM
    Transpl Immunol; 2006 Apr; 15(4):311-8. PubMed ID: 16635754
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of double-negative regulatory T cells in long-term cardiac xenograft survival.
    Chen W; Ford MS; Young KJ; Cybulsky MI; Zhang L
    J Immunol; 2003 Feb; 170(4):1846-53. PubMed ID: 12574350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of a limited T-cell receptor V beta repertoire in alloantigen recognition and allograft rejection.
    Shirwan H; Barwari L; Wang C; Cramer DV
    Transplant Proc; 1997; 29(1-2):1050-1. PubMed ID: 9123192
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunological tolerance induced by galectin-1 in rat allogeneic renal transplantation.
    Xu G; Tu W; Xu C
    Int Immunopharmacol; 2010 Jun; 10(6):643-7. PubMed ID: 20298813
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rejection of hamster cardiac xenografts by rat CD4+ or CD8+ T cells.
    Lin Y; Soares MP; Sato K; Takigami K; Csizmadia E; Anrather J; Bach FH
    Transplant Proc; 1999; 31(1-2):959-60. PubMed ID: 10083426
    [No Abstract]   [Full Text] [Related]  

  • 57. Chronic heart allograft rejection in rats demonstrates a dynamic interplay between IFN-gamma and IL-10 producing T cells.
    Köksoy S; Kakoulidis TP; Shirwan H
    Transpl Immunol; 2004 Nov; 13(3):201-9. PubMed ID: 15381203
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tolerance induced by direct inoculation of donor antigen into the thymus in low and high responder rodents.
    Alfrey EJ; Wang X; Lee L; Holm B; Kim J; Adams G; Dafoe DC
    Transplantation; 1995 Apr; 59(8):1171-6. PubMed ID: 7732564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tregs and transplantation tolerance.
    Walsh PT; Taylor DK; Turka LA
    J Clin Invest; 2004 Nov; 114(10):1398-403. PubMed ID: 15545987
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
    Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
    Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.